JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB191866

Anti-Rabbit IgG VHH Single Domain (HRP)

VHH Single Domain Anti-Rabbit IgG Fc (HRP)

5

(2 Reviews)

|

(116 Publications)

Recombinant secondary antibody suitable for IHC-P, WB, ELISA. Ideal for western blot. Cited in 116 publications.

查看别名

Ig gamma 1 chain C region, Ig gamma 3 chain C region, Ig gamma 4 chain C region, Ig gamma chain C region, Ig gamma-2 chain C region, Ig kappa-b4 chain C region, Ig kappa-b5 chain C region, Ig kappa-b9 chain C region, Ig lambda chain C region, Immunoglobin heavy constant gamma 1, Immunoglobulin G, K-BAS

14 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

IHC image of VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) staining in formalin fixed paraffin embedded normal human cerebellum tissue section.

The section was dewaxed and then pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Dako Pascal pressure cooker using the standard factory-set regime. Non-specific protein-protein interactions were then blocked using in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 3% (w/v) BSA for 1h at room temperature. The section was then incubated with rabbit monoclonal antibody [EPR12763] to NeuN (ab177487, 0.1μg/ml) in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA overnight at +4°C. Endogenous peroxidases were quenched using 1.6% (v/v) hydrogen peroxide in TBS containing 0.025% (v/v) Triton X-100 for 30 minutes at room temperature, with agitation. The secondary antibody, VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866, 1.0μg/ml) was then applied for 1 hour at room temperature in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA before being developed for 10 minutes at room temperature using Steady DAB/Plus (ab103723). The section was then counterstained with hematoxylin and mounted with DPX.

The negative control (secondary antibody only, no primary) inset shows no staining, demonstrating secondary antibody specificity.

For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • WB

Lab

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab25949 overnight at 4°C. Antibody binding was detected using VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866), and visualised using ECL development solution ab133406.

All lanes:

Western blot - Anti-RBPJK antibody (<a href='/products/primary-antibodies/rbpjk-antibody-ab25949'>ab25949</a>) at 1 µg/mL

All lanes:

Human pancreas tissue lysate - total protein (<a href='/products/unavailable/human-pancreas-tissue-lysate-total-protein-ab29816'>ab29816</a>) at 20 µg

Secondary

All lanes:

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 1/50000 dilution

Predicted band size: 56 kDa

Observed band size: 56 kDa,98 kDa

true

Exposure time: 16min

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • WB

Lab

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 1% Milk before being incubated with ab70358 overnight at 4°C. Antibody binding was detected using an anti-rabbit VHH single domain antibody conjugated to HRP, and visualised using ECL development solution ab133406.

Abcam recommends using milk as the blocking agent. Abcam welcomes customer feedback and would appreciate any comments regarding this product and the data presented above.

All lanes:

Western blot - Anti-PCK1/PEPC antibody (<a href='/products/primary-antibodies/pck1-pepc-antibody-ab70358'>ab70358</a>) at 1 µg

Lane 1:

HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 2:

Liver (Rat) Tissue Lysate at 10 µg

Lane 3:

Liver (Mouse) Tissue Lysate at 10 µg

Lane 4:

Human liver tissue lysate - total protein (<a href='/products/unavailable/human-liver-tissue-lysate-total-protein-ab29889'>ab29889</a>) at 10 µg

Secondary

All lanes:

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 1/50000 dilution

Predicted band size: 69 kDa

Observed band size: 32 kDa,45 kDa,69 kDa

true

Exposure time: 20s

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • WB

Lab

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

This blot was produced using a 4-12% Bis-tris gel under the MES buffer system. The gel was run at 200V for 35 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab16044 overnight at 4°C. Antibody binding was detected using VHH Single Domain Anti-Rabbit IgG Fc (HRP), and visualised using ECL development solution ab133406.

All lanes:

Western blot - Anti-CD3 antibody (<a href='/products/primary-antibodies/cd3-antibody-ab16044'>ab16044</a>) at 1 µg/mL

Lane 1:

Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg

Lane 2:

Thymus (Mouse) Tissue Lysate at 20 µg

Lane 3:

Thymus (Rat) Tissue Lysate at 20 µg

Secondary

All lanes:

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 1/50000 dilution

Predicted band size: 19 kDa

Observed band size: 18 kDa,23 kDa,48 kDa,62 kDa

true

Exposure time: 8min

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • WB

Lab

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab24193 overnight at 4°C. Antibody binding was detected using VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866), and visualised using ECL development solution ab133406.

All lanes:

Western blot - Anti-n-Myc/MYCN antibody (<a href='/products/primary-antibodies/n-myc-mycn-antibody-ab24193'>ab24193</a>) at 1 µg/mL

Lane 1:

Heart (Human) Whole Cell Lysate - fetal normal tissue at 10 µg

Lane 2:

Heart (Mouse) Tissue Lysate at 10 µg

Lane 3:

Skeletal Muscle (Mouse) Tissue Lysate at 10 µg

Secondary

All lanes:

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 1/50000 dilution

Predicted band size: 50 kDa

Observed band size: 190 kDa,49 kDa

true

Exposure time: 30s

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • WB

Lab

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab45145 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution ab133406

Lanes 1 - 2:

Western blot - Anti-Aurora B antibody [EP1009Y] (<a href='/products/primary-antibodies/aurora-b-antibody-ep1009y-ab45145'>ab45145</a>) at 1/1000 dilution

Lanes 3 - 4:

Western blot - Anti-Aurora B antibody [EP1009Y] (<a href='/products/primary-antibodies/aurora-b-antibody-ep1009y-ab45145'>ab45145</a>) at 1/5000 dilution

Lanes 5 - 6:

Western blot - Anti-Aurora B antibody [EP1009Y] (<a href='/products/primary-antibodies/aurora-b-antibody-ep1009y-ab45145'>ab45145</a>) at 1/10000 dilution

Lanes 7 - 8:

Western blot - Anti-Aurora B antibody [EP1009Y] (<a href='/products/primary-antibodies/aurora-b-antibody-ep1009y-ab45145'>ab45145</a>) at 1/50000 dilution

Lanes 9 - 10:

Western blot - Anti-Aurora B antibody [EP1009Y] (<a href='/products/primary-antibodies/aurora-b-antibody-ep1009y-ab45145'>ab45145</a>) at 1/75000 dilution

Lanes 1, 3, 5, 7 and 9:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Lanes 2, 4, 6, 8 and 10:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate Nocodozole Stimulated at 10 µg

Secondary

All lanes:

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 1/10000 dilution

Predicted band size: 39 kDa

Observed band size: 39 kDa

true

Exposure time: 8min

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • WB

AbReview45923****

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

Blocking Solution and Diluent 5% milk in TBS

All lanes:

Western blot - Anti-KAT3B / p300 antibody (<a href='/products/primary-antibodies/kat3b-p300-antibody-ab10485'>ab10485</a>) at 1/5000 dilution

Lane 1:

Human MCF-7 Cell Lysate at 50000 Cells

Lane 2:

MDA-MB-231 Cell Lysate at 50000 Cells

Secondary

All lanes:

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866)

Predicted band size: 264 kDa

true

Exposure time: 3min

This image is courtesy of an anonymous Abreview

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

IHC image of VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) staining in formalin fixed paraffin embedded normal human colon tissue section.

The section was dewaxed and then pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Dako Pascal pressure cooker using the standard factory-set regime. Non-specific protein-protein interactions were then blocked using in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 3% (w/v) BSA for 1h at room temperature. The section was then incubated with rabbit polyclonal antibody to VDAC1 (ab15895, 1/1000 dilution) in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA overnight at +4°C. Endogenous peroxidases were quenched using 1.6% (v/v) hydrogen peroxide in TBS containing 0.025% (v/v) Triton X-100 for 30 minutes at room temperature, with agitation. The secondary antibody, VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866, 0.125μg/ml) was then applied for 1 hour at room temperature in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA before being developed for 10 minutes at room temperature using Steady DAB/Plus (ab103723). The section was then counterstained with hematoxylin and mounted with DPX.

The negative control (secondary antibody only, no primary) insert shows no staining, demonstrating secondary antibody specificity.

For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

Top left : IHC image of VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) staining in formalin fixed paraffin embedded normal human colon tissue section.

The section was dewaxed and then pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Dako Pascal pressure cooker using the standard factory-set regime. Non-specific protein-protein interactions were then blocked using in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 3% (w/v) BSA for 1h at room temperature. The section was then incubated with rabbit polyclonal antibody to Ki67 (ab15580, 0.1μg/ml) in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA overnight at +4°C. Endogenous peroxidases were quenched using 1.6% (v/v) hydrogen peroxide in TBS containing 0.025% (v/v) Triton X-100 for 30 minutes at room temperature, with agitation. The secondary antibody, VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866, 0.1μg/ml) was then applied for 1 hour at room temperature in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA before being developed for 10 minutes at room temperature using Steady DAB/Plus (ab103723). The section was then counterstained with hematoxylin and mounted with DPX.

Top right : this image shares the same experimental design parameters, except the secondary antibody was ab97051, goat anti-rabbit IgG H&L (HRP) (0.1μg/ml). This demonstrates the improved definition of staining given by VHH Single Domain Antibodies over conventional secondaries.

Bottom right : this image shares the same experimental design parameters but is a negative control (no primary antibody) for ab97051, demonstrating specificity of the goat anti-rabbit secondary antibody.

Bottom left : this image shares the same experimental design parameters but is a negative control (no primary antibody) for ab191866, demonstrating the specificity of the VHH-Single Domain Antibody.

For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

IHC image of VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) staining in formalin fixed paraffin embedded normal human colon tissue section.

The section was dewaxed and then pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Dako Pascal pressure cooker using the standard factory-set regime. Non-specific protein-protein interactions were then blocked using in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 3% (w/v) BSA for 1h at room temperature. The section was then incubated with rabbit polyclonal antibody to beta tubulin (ab6046, 0.5μg/ml) in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA overnight at +4°C. Endogenous peroxidases were quenched using 1.6% (v/v) hydrogen peroxide in TBS containing 0.025% (v/v) Triton X-100 for 30 minutes at room temperature, with agitation. The secondary antibody, VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866, 0.125μg/ml) was then applied for 1 hour at room temperature in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA before being developed for 10 minutes at room temperature using Steady DAB/Plus (ab103723). The section was then counterstained with hematoxylin and mounted with DPX.

The negative control (secondary antibody only, no primary) inset shows no staining, demonstrating secondary antibody specificity.

For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

IHC image of VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) staining in formalin fixed paraffin embedded normal human colon tissue section.

The section was dewaxed and then pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Dako Pascal pressure cooker using the standard factory-set regime. Non-specific protein-protein interactions were then blocked using in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 3% (w/v) BSA for 1h at room temperature. The section was then incubated with rabbit polyclonal antibody to Ki67 (ab15580, 0.1μg/ml) in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA overnight at +4°C. Endogenous peroxidases were quenched using 1.6% (v/v) hydrogen peroxide in TBS containing 0.025% (v/v) Triton X-100 for 30 minutes at room temperature, with agitation. The secondary antibody, VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866, 0.025μg/ml) was then applied for 1 hour at room temperature in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA before being developed for 10 minutes at room temperature using Steady DAB/Plus (ab103723). The section was then counterstained with hematoxylin and mounted with DPX.

The negative control (secondary antibody only, no primary) inset shows no staining, demonstrating secondary antibody specificity.

For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • WB

Lab

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

This blot was produced using a 4-12% Bis-tris gel under the MES buffer system. The gel was run at 200V for 35 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab5823 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution ab133406.

All lanes:

Western blot - Anti-Histone H4 (symmetric di methyl R3) antibody (<a href='/products/primary-antibodies/histone-h4-symmetric-di-methyl-r3-antibody-ab5823'>ab5823</a>) at 1 µg

All lanes:

Calf Thymus Histone Preparation Nuclear Lysate at 0.5 µg

Secondary

All lanes:

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 1/50000 dilution

Predicted band size: 11 kDa

Observed band size: 14 kDa

true

Exposure time: 3min

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • WB

Lab

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

All lanes:

Western blot - Anti-GAPDH antibody - Loading Control (<a href='/products/primary-antibodies/gapdh-antibody-loading-control-ab37168'>ab37168</a>) at 1 µg/mL

Lanes 1 and 3:

HeLa Whole Cell Lysate at 10 µg

Lanes 2 and 4:

Jurkat Whole Cell Lysate at 10 µg

Secondary

Lanes 1 - 2:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 0.02 µg/mL

Lanes 3 - 4:

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 0.02 µg/mL

Predicted band size: 11 kDa,54 kDa

true

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
  • WB

Lab

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)

All lanes:

Western blot - Anti-NRG1 type III antibody (<a href='/products/primary-antibodies/nrg1-type-iii-antibody-ab23248'>ab23248</a>) at 1 µg/mL

Lanes 1 and 3:

Mouse Brain Tissue Lysate at 10 µg

Lanes 2 and 4:

Rat Brain Tissue Lysate at 10 µg

Secondary

Lanes 1 - 2:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 0.05 µg/mL

Lanes 3 - 4:

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 0.05 µg/mL

Predicted band size: 11 kDa

true

关键信息

靶标种属

Rabbit

靶标亚型

IgG

靶标特异性

Fc region

最低交叉反应
预吸附

No

偶联物

HRP

激发波长/发射波长
应用

ELISA, IHC-P, WB

applications

克隆

Monoclonal

克隆号

GD001

特异性

This antibody is a VHH single Domain antibody that recognises Rabbit IgG Fc region.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"0.02000-0.20000 µg/mL", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification His Tag
纯化说明
This product is a recombinant protein produced in E. coli.
存储溶液
pH: 7.4 Preservative: 0.1% Proclin 300 Solution Constituents: Sodium phosphate, Sodium chloride, PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
储存信息
Avoid freeze / thaw cycle|Store in the dark

产品实验方案

文献 (116)

Recent publications for all applications. Explore the full list and refine your search

Npj viruses 3:66 PubMed40913022

2025

Development of GFP-expressing infectious clones for PRRSV using TAR cloning for antiviral drug screening.

Applications

Unspecified application

Species

Unspecified reactive species

Minze Zhang,Bang Qian,Dusan Kunec,Michael Veit

Journal of cancer research and clinical oncology 150:380 PubMed39095579

2024

Pokemon inhibits Bim transcription to promote the proliferation, anti-anoikis, invasion, histological grade, and dukes stage of colorectal neoplasms.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Wang,Huiling Zeng,Li Li,Jizhen Liu,Jiantao Lin,Yanhong Bie,Sen Wang,Xiaoguang Cheng,Bayaer Nashun,Yunhong Yao,Xinrong Hu,Yi Zhao

Veterinary microbiology 294:110125 PubMed38795404

2024

Engineering and characterizing porcine reproductive and respiratory syndrome virus with separated and tagged genes encoding the minor glycoproteins.

Applications

Unspecified application

Species

Unspecified reactive species

Minze Zhang,Bang Qian,Michael Veit

International journal of molecular sciences 24: PubMed38139144

2023

Dose-Dependent Effect of Mitochondrial Superoxide Dismutase Gene Overexpression on Radioresistance of HEK293T Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Marina M Tavleeva,Elena E Rasova,Anna V Rybak,Elena S Belykh,Elizaveta A Fefilova,Elizaveta M Pnachina,Ilya O Velegzhaninov

Scientific reports 13:18928 PubMed37919373

2023

The role of an amphiphilic helix and transmembrane region in the efficient acylation of the M2 protein from influenza virus.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaorong Meng,Clark Templeton,Cecilia Clementi,Michael Veit

Journal of virology 97:e0124523 PubMed37792001

2023

Palmitoylation of the hemagglutinin of influenza B virus by ER-localized DHHC enzymes 1, 2, 4, and 6 is required for efficient virus replication.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaorong Meng,Michael Veit

Porcine health management 9:18 PubMed37069650

2023

Differential impact of yeast cell wall products in recovery of porcine intestinal epithelial cell barrier function following Lipopolysaccharide challenge.

Applications

Unspecified application

Species

Unspecified reactive species

Niall Browne,Daniel Daly,Karina Horgan

Cancers 15: PubMed36980752

2023

Non-Oncogene Addiction of -Mutant Cancers to IL-1β via Versican and Mononuclear IKKβ.

Applications

Unspecified application

Species

Unspecified reactive species

Magda Spella,Giannoula Ntaliarda,Georgios Skiadas,Anne-Sophie Lamort,Malamati Vreka,Antonia Marazioti,Ioannis Lilis,Eleni Bouloukou,Georgia A Giotopoulou,Mario A A Pepe,Stefanie A I Weiss,Agnese Petrera,Stefanie M Hauck,Ina Koch,Michael Lindner,Rudolph A Hatz,Juergen Behr,Kristina A M Arendt,Ioanna Giopanou,David Brunn,Rajkumar Savai,Dieter E Jenne,Maarten de Château,Fiona E Yull,Timothy S Blackwell,Georgios T Stathopoulos

BMC research notes 16:39 PubMed36941637

2023

An animal-free preclinical drug screening platform based on human precision-cut kidney slices.

Applications

Unspecified application

Species

Unspecified reactive species

Henricus A M Mutsaers,Michael Schou Jensen,Jean-Claude Kresse,Stine Julie Tingskov,Mia Gebauer Madsen,Rikke Nørregaard

Heliyon 9:e14171 PubMed36938470

2023

Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Tingting Zhao,Qian Xiang,Beifeng Lie,Deqi Chen,Minyi Li,Xi Zhang,Junzheng Yang,Bao He,Wei Zhang,Ruixue Dong,Yadi Liu,Junling Gu,Quan Zhu,Yijing Yao,Tingting Duan,Zhenghai Li,Youhua Xu
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com